Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09RMZ
|
|||
| Former ID |
DIB015616
|
|||
| Drug Name |
HibTITER
|
|||
| Synonyms |
Haemophilus vaccine II, Praxis; Conjugate vaccine (Haemophilus influenzae type B/ meningitis), Nuron Biotech
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Pneumococcal infection [ICD-11: CA00-CA40; ICD-10: A00-B99; ICD-9: 001-139] | Phase 2 | [1] | |
| Company |
Nuron biotech
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Haemophilus influenzae CRM197 (Hae-influ CRM197) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011380) | |||
| REF 2 | Immunogenicity and safety of Haemophilus influenzae type b conjugate vaccine (HibTITER) and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER (TETRAMUNE) in two-month-old infants. J Microbiol Immunol Infect. 1998 Sep;31(3):180-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.